Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
October 14, 2024
Not intended for U.S. and UK Media
Bayer submits application for third indication of darolutamide in the EU
September 27, 2024
Not intended for UK Media
BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months
September 26, 2024
Not intended for U.S. and UK Media
Bayer submits application to U.S. FDA for third indication of darolutamide
Discover More
